Fisher & Paykel Healthcare (FPH) investor relations material

Opening remarks and agenda

• Chair welcomed shareholders in person and online, confirmed quorum, and introduced board members and executives.

• Meeting agenda included addresses from the Chair and CEO, review of financial statements, resolutions, voting, and a general Q&A session.

• Agenda included the Chair's address, CEO's financial and operational update, Q&A on financial statements, and formal resolutions.

Financial performance review

• FY26 operating revenue reached NZD 2.31 billion, up 12% in constant currency.

• Net profit after tax was NZD 468.5 million, a 28% increase in constant currency.

• Gross margin improved by 122 basis points to 63.7%, despite increased costs from tariffs and global events.

• Dividend increased by 38% to NZD 0.52 per share, with a payout ratio of 65%.

• FY27 guidance projects operating revenue of NZD 2.47–2.57 billion and net profit after tax of NZD 525–565 million.

Board and executive committee updates

• Anna Curzon joined the board in February and stood for election.

• Margie Apa participated as Future Director under the Future Directors program.

• Board composition includes eight named members.

• Board composition and director remuneration reviewed, with benchmarking by Mercer.